Singapore markets closed

Cyclerion Therapeutics, Inc. (CYCN)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
3.1200+0.0200 (+0.65%)
At close: 4:00PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close3.1000
Open3.1500
Bid3.2200 x 800
Ask3.3900 x 1200
Day's range3.0700 - 3.4664
52-week range2.0800 - 8.3400
Volume927,753
Avg. volume602,630
Market cap135.023M
Beta (5Y monthly)1.85
PE ratio (TTM)N/A
EPS (TTM)-1.9900
Earnings date25 Feb 2021
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Motley Fool

    Why Cyclerion Therapeutics Is Crashing Today

    Shares of clinical-stage biotech Cyclerion Therapeutics (NASDAQ: CYCN) are down by an eye-popping 48% as of noon EDT Wednesday. The small-cap biotech's stock is crashing in response to a negative midstage trial result for its sickle cell disease candidate olinciguat. Sickle cell disease is a rare blood disorder with limited treatment options.